NASDAQ · Biotechnology

HilleVax, Inc. (HLVX) Stock

$2.09 -0.48% NASDAQ: HLVX Healthcare

HilleVax, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the creation and market introduction of innovative vaccines.

Valuation

MetricValue
Price$2.09
Market Cap$104.76M
P/E Ratio-9.09
P/B Ratio0.71
P/S Ratio0.00
EPS (TTM)$-3.00
52-Week High$2.17
52-Week Low$1.34
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-7.58%
ROA-6.48%
ROCE-8.64%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.16
Current Ratio26.39

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-53.0M$-65.0M$-133.0M$-155.0M
Net Profit$-2.0M$-85.0M$-257.0M$-124.0M$-147.0M
EPS$-0.07$-2.82$-6.83$-3.04$-3.00
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$1.0M$127.0M$317.0M$344.0M$193.0M
Total Liabilities$3.0M$228.0M$50.0M$79.0M$38.0M
Cash$0$125.0M$279.0M$217.0M$154.0M
Borrowings$3.0M$158.0M$36.0M$51.0M$25.0M

Latest News

The longer we live, the more we worry: AIA Longevity Study finds Singaporeans view longevity with more anxiety than opportunity PR Newswire · Jul 23, 2026 Dow Jones Futures: Google, Tesla Fall On Earnings, Capital Spending Investor's Business Daily · Jul 23, 2026 Australia jobs blow past expectations in June, cements bets of another rate rise Reuters · Jul 23, 2026 Bitwise CIO Names 2 Crypto Bets Best Positioned for the Next Bull Market BeInCrypto · Jul 23, 2026 MegazoneCloud and Korean Re Sign Strategic Agreement to Advance AX PR Newswire · Jul 23, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-1.0M$-7.0M$-62.0M$-87.0M$-109.0M
Investing Cash Flow$0$-6.0M$-13.0M$-105.0M$58.0M
Financing Cash Flow$1.0M$-1.0M$0$0$0
Net Cash Flow$0$124.0M$156.0M$-63.0M$-62.0M
Free Cash Flow$-1.0M$-10.0M$-69.0M$-98.0M$-109.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.10
EV / EBITDA-6.72
FCF Yield-12.89%
Quick Ratio26.39
Interest Coverage-51.67
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AADIAadi Bioscience, Inc. $2.05 -2.38% -1.49 $94.89M 0.00%
BLIBerkeley Lights, Inc. $1.20 -5.88% -0.85 $86.61M 0.00%
CYTCyteir Therapeutics, Inc. $3.02 -2.27% -2.42 $108.71M 0.00%
DBTXDecibel Therapeutics, Inc. $4.91 -0.81% -1.95 $123.37M 0.00%
IMDXInsight Molecular Diagnostics Inc. $4.70 -0.84% -3.13 $151.76M 0.00%

About HilleVax, Inc.

HilleVax, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the creation and market introduction of innovative vaccines. The company's lead investigational product is HIL-214, a vaccine candidate utilizing virus-like particles, which aims to prevent moderate-to-severe acute gastroenteritis resulting from norovirus infections. Its corporate headquarters are located in Boston, Massachusetts.

HilleVax, Inc. is headquartered in US.

HilleVax, Inc. (HLVX) stock trades at $2.09 with a market capitalization of $104.76M. The stock is valued at a price-to-earnings (P/E) ratio of -9.09, price-to-book of 0.71, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.34 and $2.17, and currently trades 3.7% below its 52-week high.

On profitability, HilleVax, Inc. generates a return on equity (ROE) of -7.58%, return on capital employed of -8.64%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.hillevax.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides